Text and Data Mining valid from 2018-05-15
Received: 21 February 2018
Revised: 23 April 2018
Accepted: 25 April 2018
First Online: 15 May 2018
Ethics approval and consent to participate
: The study was conducted in strict adherence to the tenets of the Declaration of Helsinki, and it was retrospectively registered in ClinicalTrials.gov (Identifier: NCT03427905). The protocol was approved by the institutional review board of REVIVA Regenerative Medicine Center at the Middle East Institute of Health University Hospital as previously [CitationRef removed, CitationRef removed] under the academic regulations of the public institution, the Lebanese University. All patients provided written informed consent and fresh samples were procured by Dr. Rami Andari (plastic surgeon) from REVIVA at the Middle East Institute of Health (MEIH) University Hospital. The first patient was enrolled in March 2013.
: The authors declare that they have no competing interests related to this study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.